{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:41:50Z","timestamp":1770918110940,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CSU Program for Education and Research in Biotechnology"},{"name":"CSU Program for Education and Research in Biotechnology"},{"name":"CSU Program for Education and Research in Biotechnology"},{"name":"CSU Program for Education and Research in Biotechnology"},{"name":"California State University Chico Internal Research Grant"},{"name":"California State University Chico Internal Research Grant"},{"name":"Student Research and Creativity Awards from California State University, Chico"},{"name":"Student Research and Creativity Awards from California State University, Chico"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236839","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T18:52:33Z","timestamp":1597171953000},"page":"e0236839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation"],"prefix":"10.1371","volume":"15","author":[{"given":"Tina R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kallie","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen F.","family":"Rueb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Holmberg-Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skylar","family":"Tomasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-0938","authenticated-orcid":true,"given":"David L.","family":"Stachura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolynn C.","family":"Arpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"pone.0236839.ref001","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.25.022106.141538","article-title":"Ontogeny of the hematopoietic system","volume":"25","author":"A Cumano","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"pone.0236839.ref002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"SH Orkin","year":"2008","journal-title":"Cell"},{"issue":"17","key":"pone.0236839.ref003","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","article-title":"Hematopoietic stem cells: concepts, definitions, and the new reality","volume":"125","author":"CJ Eaves","year":"2015","journal-title":"Blood"},{"issue":"6774","key":"pone.0236839.ref004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages","volume":"404","author":"K Akashi","year":"2000","journal-title":"Nature"},{"issue":"18","key":"pone.0236839.ref005","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.172384399","article-title":"Prospective isolation of human clonogenic common myeloid progenitors","volume":"99","author":"MG Manz","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0236839.ref006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils","volume":"9","author":"TN Mayadas","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"pone.0236839.ref007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days","volume":"116","author":"J Pillay","year":"2010","journal-title":"Blood"},{"issue":"8","key":"pone.0236839.ref008","first-page":"2213","article-title":"Lymphosarcoma: virus-induced thymic-independent disease in mice","volume":"30","author":"HT Abelson","year":"1970","journal-title":"Cancer Res"},{"issue":"5940","key":"pone.0236839.ref009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"CR Bartram","year":"1983","journal-title":"Nature"},{"issue":"1","key":"pone.0236839.ref010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22","volume":"36","author":"J Groffen","year":"1984","journal-title":"Cell"},{"key":"pone.0236839.ref011","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"PC Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"issue":"5405","key":"pone.0236839.ref012","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"JD Rowley","year":"1973","journal-title":"Nature"},{"issue":"7","key":"pone.0236839.ref013","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/MCB.01454-13","article-title":"The capable ABL: what is its biological function?","volume":"34","author":"JY Wang","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"6325","key":"pone.0236839.ref014","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/351400a0","article-title":"Bcr encodes a GTPase-activating protein for p21rac","volume":"351","author":"D Diekmann","year":"1991","journal-title":"Nature"},{"issue":"3","key":"pone.0236839.ref015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0092-8674(91)90521-Y","article-title":"The BCR gene encodes a novel serine\/threonine kinase activity within a single exon","volume":"67","author":"Y Maru","year":"1991","journal-title":"Cell"},{"issue":"1","key":"pone.0236839.ref016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.181.1.307","article-title":"Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene","volume":"181","author":"CL Sawyers","year":"1995","journal-title":"J Exp Med"},{"issue":"2","key":"pone.0236839.ref017","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","article-title":"Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells","volume":"86","author":"T Skorski","year":"1995","journal-title":"Blood"},{"issue":"21","key":"pone.0236839.ref018","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1111\/j.1742-4658.2010.07865.x","article-title":"Docking proteins","volume":"277","author":"T Brummer","year":"2010","journal-title":"FEBS J"},{"issue":"2","key":"pone.0236839.ref019","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/cells3020304","article-title":"Mechanisms of activation of receptor tyrosine kinases: monomers or dimers","volume":"3","author":"IN Maruyama","year":"2014","journal-title":"Cells"},{"issue":"5","key":"pone.0236839.ref020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(93)90404-E","article-title":"SH2 domains recognize specific phosphopeptide sequences","volume":"72","author":"Z Songyang","year":"1993","journal-title":"Cell"},{"issue":"3","key":"pone.0236839.ref021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(92)90167-B","article-title":"The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling","volume":"70","author":"EJ Lowenstein","year":"1992","journal-title":"Cell"},{"key":"pone.0236839.ref022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1242\/jcs.1994.Supplement_18.14","article-title":"Structure and function of SH2 domains","volume":"18","author":"LE Marengere","year":"1994","journal-title":"J Cell Sci Suppl"},{"issue":"5208","key":"pone.0236839.ref023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.7716522","article-title":"Crystal structure of the mammalian Grb2 adaptor","volume":"268","author":"S Maignan","year":"1995","journal-title":"Science"},{"issue":"4","key":"pone.0236839.ref024","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"L Puil","year":"1994","journal-title":"EMBO J"},{"issue":"2","key":"pone.0236839.ref025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","article-title":"The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase","volume":"96","author":"RP Million","year":"2000","journal-title":"Blood"},{"issue":"5","key":"pone.0236839.ref026","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","article-title":"Critical role for Gab2 in transformation by BCR\/ABL","volume":"1","author":"M Sattler","year":"2002","journal-title":"Cancer Cell"},{"issue":"2","key":"pone.0236839.ref027","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"T O'Hare","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"pone.0236839.ref028","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"BJ Druker","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"pone.0236839.ref029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnci\/91.2.163","article-title":"In vivo eradication of human BCR\/ABL-positive leukemia cells with an ABL kinase inhibitor","volume":"91","author":"P le Coutre","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"pone.0236839.ref030","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0236839.ref031","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"TL Holyoake","year":"2017","journal-title":"Blood"},{"issue":"3","key":"pone.0236839.ref032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?","volume":"14","author":"G Rosti","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1\u20133","key":"pone.0236839.ref033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"pone.0236839.ref034","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1016\/S0968-0896(03)00399-7","article-title":"Synthesis and structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as non-peptide, small-molecule antagonists for interleukin-8 receptor","volume":"11","author":"JJ Li","year":"2003","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"pone.0236839.ref035","first-page":"380","article-title":"Synthesis, Pharmacological Evaluation and QSAR Study of 2-aryl- 1H-[1, 3,4] oxadiazino [5, 6-b] quinoxalines as Antidepressants","volume":"3","author":"MR Surywanshi","year":"2011","journal-title":"Archives of Applied Science Research"},{"issue":"5","key":"pone.0236839.ref036","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1006\/jmbi.2001.5299","article-title":"Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor","volume":"315","author":"P Nioche","year":"2002","journal-title":"J Mol Biol"},{"issue":"12","key":"pone.0236839.ref037","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1128\/MCB.13.12.7278","article-title":"Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides","volume":"13","author":"KB Bibbins","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"9","key":"pone.0236839.ref038","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1074\/jbc.273.9.5343","article-title":"Differential interactions of the growth factor receptor-bound protein 2 N-SH3 domain with son of sevenless and dynamin. Potential role in the Ras-dependent signaling pathway","volume":"273","author":"M Vidal","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0236839.ref039","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood-2009-02-203638","article-title":"Zebrafish kidney stromal cell lines support multilineage hematopoiesis","volume":"114","author":"DL Stachura","year":"2009","journal-title":"Blood"},{"key":"pone.0236839.ref040","volume-title":"The Zebrafish Book. A guide for the laboratory use of zebrafish (Danio rerio)","author":"M. Westerfield","year":"2007","edition":"5"},{"issue":"9","key":"pone.0236839.ref041","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood.V96.9.3195","article-title":"Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells","volume":"96","author":"JT Thiesing","year":"2000","journal-title":"Blood"},{"issue":"7147","key":"pone.0236839.ref042","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"TE North","year":"2007","journal-title":"Nature"},{"issue":"1","key":"pone.0236839.ref043","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/zeb.2009.0643","article-title":"A chemical genetic screen in zebrafish for pathways interacting with cdx4 in primitive hematopoiesis","volume":"7","author":"EJ Paik","year":"2010","journal-title":"Zebrafish"},{"issue":"24","key":"pone.0236839.ref044","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1182\/blood-2011-12-398818","article-title":"Zebrafish screen identifies novel compound with selective toxicity against leukemia","volume":"119","author":"S Ridges","year":"2012","journal-title":"Blood"},{"issue":"4","key":"pone.0236839.ref045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nchembio.147","article-title":"Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation","volume":"5","author":"JR Yeh","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"5","key":"pone.0236839.ref046","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.12186","article-title":"Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib","volume":"93","author":"P La Rosee","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"pone.0236839.ref047","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bmc.2010.10.030","article-title":"Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists","volume":"19","author":"ND Ambaye","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"pone.0236839.ref048","first-page":"52","article-title":"One-pot three-component synthesis of quinoxaline and phenazine ring systems using Fischer carbene complexes","volume":"6","author":"P Roy","year":"2010","journal-title":"Beilstein J Org Chem"},{"issue":"12","key":"pone.0236839.ref049","first-page":"738","article-title":"Synthesis and pharmacological evaluation of novel quinoxalines as potential nonulcerogenic anti-inflammatory and analgesic agents","volume":"55","author":"MM Ismail","year":"2005","journal-title":"Arzneimittelforschung"},{"issue":"30","key":"pone.0236839.ref050","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1039\/c3ob41069b","article-title":"Transition metal free hydrolysis\/cyclization strategy in a single pot: synthesis of fused furo N-heterocycles of pharmacological interest","volume":"11","author":"A Nakhi","year":"2013","journal-title":"Org Biomol Chem"},{"issue":"7","key":"pone.0236839.ref051","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1248\/yakushi1947.97.7_712","article-title":"[Quinoxalines. XXI. Synthesis of 2-substituted furo(2,3-b)quinoxaline and 2-substituted pyrrolo(2,3-b)quinoxaline (author's transl)]","volume":"97","author":"C Iijima","year":"1977","journal-title":"Yakugaku Zasshi"},{"issue":"5","key":"pone.0236839.ref052","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bmc.2012.01.012","article-title":"AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono\/disubstituted quinoxalines as potential antitubercular agents","volume":"20","author":"KS Kumar","year":"2012","journal-title":"Bioorg Med Chem"},{"issue":"18","key":"pone.0236839.ref053","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1021\/jo3014275","article-title":"Cu-catalyzed reaction of 1,2-dihalobenzenes with 1,3-cyclohexanediones for the synthesis of 3,4-dihydrodibenzo[b,d]furan-1(2H)-ones","volume":"77","author":"N Aljaar","year":"2012","journal-title":"J Org Chem"},{"key":"pone.0236839.ref054","first-page":"1","volume-title":"Organic Reactions","author":"RA Rossi","year":"2004"},{"key":"pone.0236839.ref055","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1021\/jo00345a028","article-title":"SRN1 Mechanism in Heteroaromatic Nucleophilic Substitution. Reactions of 2-Chloroquinoxaline and 4-Chloroquinazolines with Ketone Enolates","volume":"47","author":"DR Carver","year":"1982","journal-title":"Journal of Organic Chemistry"},{"key":"pone.0236839.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2016.09.012","article-title":"Using zebrafish models of leukemia to streamline drug screening and discovery","volume":"45","author":"AP Deveau","year":"2017","journal-title":"Exp Hematol"},{"key":"pone.0236839.ref057","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.ctdb.2016.10.007","article-title":"Zebrafish in Toxicology and Environmental Health","volume":"124","author":"K Bambino","year":"2017","journal-title":"Curr Top Dev Biol"},{"issue":"4","key":"pone.0236839.ref058","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"WW Chan","year":"2011","journal-title":"Cancer Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T18:54:28Z","timestamp":1597172068000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236839"}},"subtitle":[],"editor":[{"given":"Laszlo","family":"Buday","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]}}}